Price Alert

Acumen Pharmaceuticals In... (ABOS)

NASDAQ: ABOS · Real-Time Price · USD

2.13

-0.15 (-6.58%)

At close: Oct 16, 2025, 3:59 PM

2.11

-0.94%

After-hours: Oct 16, 2025, 07:31 PM EDT

-6.58% (1D)

Bid	2.01
Market Cap	129.02M
Revenue (ttm)	178K
Net Income (ttm)	-136.66M
EPS (ttm)	-2.27
PE Ratio (ttm)	-0.94
Forward PE	-1.4
Analyst	Buy
Dividends	n/a

Ask	2.23
Volume	277,165
Avg. Volume (20D)	348,868
Open	2.28
Previous Close	2.28
Day's Range	2.12 - 2.32
52-Week Range	0.85 - 3.36
Beta	0.20
Ex-Dividend Date	n/a

About ABOS

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol ABOS

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for ABOS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

2 months ago

-11.27%

Acumen Pharmaceuticals shares are trading lower af... Unlock content with Pro Subscription

News

1 month ago · seekingalpha.com

Acumen Pharmaceuticals, Inc. (ABOS) Presents At Citi's Biopharma Back To School Conference Transcript

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS ) Citi's Biopharma Back to School Conference September 2, 2025 3:15 PM EDT Company Participants Daniel O'Connell - CEO & Director Matt Zuga - CFO & Chief Busi...

2 months ago · seekingalpha.com

Acumen Pharmaceuticals, Inc. (ABOS) Q2 2025 Earnings Call Transcript

Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS ) Q2 2025 Earnings Conference Call August 12, 2025 8:00 AM ET Company Participants Alex Braun - VP & Head of Investor Relations Daniel J. O'Connell - CEO & Di...